Biologics: The Pharmaceutical Future from Phase 1 and Beyond

01/28/2010 - 01/29/2010
Boston, MA

Conference Partners

Media Partners
Understanding trends, identifying new markets, and creating revenue building partnerships: Maximizing success and mastering the highly competitive and dynamic Biologics marketplace
A Two-Day Forum highlighting the most current case studies and sales strategies from top Pharmaceutical Institutions. Learn about:
• Keeping ahead of trends in biopharmaceuticals manufacturing
• Implementing new sales methods to achieve cost reductions
• Strategic approaches to maximizing the opportunities and minimizing threats of biosimilars
• What investors are looking for in the biopharmaceutical sector
• Successful business models for the future
• Current Pharma industry’s changing environment creating new biologics opportunities
• Evolution of bio-outsourcing in the next 10 years
• Developing a clinical outsourcing strategy
• Big Pharma to Big Biopharma – what does that mean for current biologics sellers
• Establishing and safeguarding a profitable approach to follow-on biologics
• How does biosimilar competition really affect market value of biologics
DISTINGUISHED SPEAKING FACULTY INCLUDES:
Marc Samuels, MPH, JD, President HillCo Health, Washington, DC
Randy Vogenberg, Executive Director Biologic Finance & Access Council (BFAC) Sharon, MA
Philippe Stas, Chief Executive Officer Algonomics, Gent, Belgium
Boro Dropulic, Ph.D., MBA, Founder, President & CEO Lentigen Corporation, Gaithersburg, MD
Caleb DesRosiers, MPA, JD, Vice President, Government Strategy & Legal Affairs, HillCo Health, Washington, DC
Ronald Evens, Pharm.D., FCCP, President and Clinical Professor, M.A.P.S. 4 Biotech, Inc., University of Florida Jacksonville, FL
Grace Wong, PhD, CEO, ActoKine Therapeutics Chestnut Hill, MA
Robert E. Ward, Vice President, Corporate Development NPS Pharmaceuticals Inc., Bedminster, NJ
Jeffrey M. Bockman, PhD, Vice President Defined Health, Florham Park, NJ
Michael C. Rice, MS. MBA, Senior Consultant Defined Health, Florham Park, NJ
And More! • VP/Director Business Development
WHO SHOULD ATTEND?
The conference is ideally suited for the senior level executives, directors or division chiefs of pharmaceutical/biologic sales organizations
• Senior Level Administrators
• Executive Directors
• Scientific Managers
• Project & Quality Assurance Managers
• National Sales Managers
• Director of Pharma Sales
• VP/Director of Marketing/Planning/PR
© 2007 Active Communications International.
All rights reserved. Terms of use | Privacy policy